Phase II trial of an HIV DNA vaccine (VRC-HIVDNA016-00-vp) boosted with an adenoviral vector-based HIV vaccine (VRC-HIVADV014-00-vp) in healthy subjects.

Trial Profile

Phase II trial of an HIV DNA vaccine (VRC-HIVDNA016-00-vp) boosted with an adenoviral vector-based HIV vaccine (VRC-HIVADV014-00-vp) in healthy subjects.

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 24 Oct 2013

At a glance

  • Drugs VRC-HIVADV014-00-VP (Primary) ; VRC-HIVDNA016-00-VP (Primary)
  • Indications HIV infections
  • Focus Pharmacodynamics
  • Most Recent Events

    • 24 Oct 2013 replaced 204 identifier, as per info in RDI. Added other MRs and extra info
    • 21 Oct 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top